|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/57 | |
| A61P 5/36 | |||
| A61P 15/00 | |||
| A61K 9/20 |
| (11) | Number of the document | 2684565 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13187859.7 |
| Date of filing the European patent application | 2009-01-28 | |
| (97) | Date of publication of the European application | 2014-01-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 21610 | 2008-01-29 | US |
| (72) |
Gainer, Erin, FR
Nieman, Lynnette, US
Ulmann, André, FR
Blithe, Diana, US
|
| (73) |
The United States of America as represented by the Secretary, Department of Health and Human Services,
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, Bethesda, MD 20892-7660,
US
Laboratoire HRA-Pharma, 200 avenue de Paris, 92320 Chātillon, FR |
| (54) | USE OF ULIPRISTAL ACETATE FOR TREATING UTERINE FIBROIDS |
| USE OF ULIPRISTAL ACETATE FOR TREATING UTERINE FIBROIDS |